[1]
M. F. da M. S. V. Gontijo, L. M. de A. C. Linhares, L. L. de S. Campos, M. de O. Sá, and C. C. Avelar, “28457 – EPIDEMIOLOGICAL AND CLINICOPATHOLOGICAL PARAMETERS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER DURING THE COVID-19 PANDEMIC”, MAST, vol. 34, no. suppl.2, Feb. 2026.